Live Breaking News & Updates on Director Matthew

Stay updated with breaking news from Director matthew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Unintended consequences of Maryland's 'Dignity Not Detention' spark widespread criticism

Following every arrest, Maryland's federal immagration enforcement agents conduct what’s called a clean-up, which involves hand cuffing the detainee more comfor ....

United States , El Salvador , Matthew Elliston , Jeremy Eldridge , Customs Enforcement , Director Matthew , Dignity Not Detention Act , Dignity Not Detention ,

EZCORP (NASDAQ:EZPW) Stock Price Down 3.9%

EZCORP, Inc. (NASDAQ:EZPW – Get Free Report)’s stock price fell 3.9% on Monday . The company traded as low as $10.07 and last traded at $10.07. 179,539 shares traded hands during mid-day trading, a decline of 67% from the average session volume of 544,803 shares. The stock had previously closed at $10.48. Analysts Set New […] ....

United States , Nicole Swies , Dekabank Deutsche Girozentrale , Mattheww Appel , Cornerstone Investment Partners , Canaccord Genuity Group , Allspring Global Investments Holdings , Company Profile , Corton Capital Inc , Securities Exchange Commission , Ezcorp Inc , Get Free Report , Genuity Group , Director Matthew , Exchange Commission , Bank Deutsche Girozentrale , Global Investments Holdings , Latin America Pawn ,

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director Matthew L. Posard Sells 10,000 Shares

Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […] ....

United States , Matthewl Posard , Piper Sandler , Principal Securities Inc , Securities Exchange Commission , Wells Fargo Company , Rise Advisors , Halozyme Therapeutics Inc , First Horizon Advisors Inc , Halozyme Therapeutics Company Profile , Fidelis Capital Partners , Whittier Trust Co , Halozyme Therapeutics , Get Free Report , Director Matthew , Exchange Commission , Capital Partners , First Horizon Advisors , Horizon Advisors , Halozyme Therapeutics Daily ,